Cargando…

Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study

OBJECTIVE: To validate the Chinese version of the Quality of Life (QoL) Patient/Cancer Survivor Version (QOLCSV-C) for measuring QoL in Chinese cancer survivors. METHODS: The study followed a seven-step research practice guideline for cross-cultural research instrument validation study including tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hai-Ying, Hang Kwok, Stephen Wai, Liu, Xian-Liang, Wang, Tao, Bressington, Daniel, Shen, Yushan, Zhang, Qing, Huang, Hou-Qiang, Tan, Jing-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372171/
https://www.ncbi.nlm.nih.gov/pubmed/37519402
http://dx.doi.org/10.1016/j.apjon.2023.100255
_version_ 1785078314073849856
author Wang, Hai-Ying
Hang Kwok, Stephen Wai
Liu, Xian-Liang
Wang, Tao
Bressington, Daniel
Shen, Yushan
Zhang, Qing
Huang, Hou-Qiang
Tan, Jing-Yu
author_facet Wang, Hai-Ying
Hang Kwok, Stephen Wai
Liu, Xian-Liang
Wang, Tao
Bressington, Daniel
Shen, Yushan
Zhang, Qing
Huang, Hou-Qiang
Tan, Jing-Yu
author_sort Wang, Hai-Ying
collection PubMed
description OBJECTIVE: To validate the Chinese version of the Quality of Life (QoL) Patient/Cancer Survivor Version (QOLCSV-C) for measuring QoL in Chinese cancer survivors. METHODS: The study followed a seven-step research practice guideline for cross-cultural research instrument validation study including translation, adaptation, and psychometric assessment. A forward- and backward-translation procedure was approached, followed by cultural adaptation and acceptability assessment. For its psychometric properties, its concurrent validity with the Functional Assessment of Cancer Therapy-General (FACT-G) was examined with correlation analysis. The internal consistency (Cronbach's alpha) and item-total and item–subtotal correlations of the QOLCSV-C were obtained. Factor analyses were conducted. Floor and ceiling effects and the discriminant performance of the selected variables on QOLCSV-C score were also examined. RESULTS: The QOLCSV-C was translated from the 41-item QOLCSV with four domains: psychological, physical, spiritual and social well-being. The content validity was excellent (CVI ​= ​1.00). Time spent to complete the QOLCSV-C was about 10 ​min. The QOLCSV-C was found easy to use, appropriate in length, and reflective of their QoL. The strong correlation between QOLCSV-C and FACT-G indicates a satisfactory concurrent validity (Spearman's rho ​= ​0.765, P ​< ​0.001, n ​= ​205). The overall internal consistency of the QOLCSV-C (Cronbach's alpha ​= ​0.888) and the split-half reliability (Spearman-Brown r ​= ​0.918) were excellent. Most of the items show moderate to strong item-total correlation. The exploratory factor analysis revealed a four-factor solution, and confirmatory factor analysis has a satisfactory model fit with indicative items. None of the total scores of QOLCSV-C reveal the floor or ceiling effect. For discriminant performance, variables demonstrating significant between-group differences include sleep quality, pain, fatigue, nausea, physical health, and financial burden. CONCLUSIONS: The QOLCSV-C is a reliable and valid instrument for measuring the QoL in Chinese cancer survivors. Future studies can explore the factor structure, gender universal or specific items, and significant predictors of QoL of cancer survivors in different cultures.
format Online
Article
Text
id pubmed-10372171
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103721712023-07-28 Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study Wang, Hai-Ying Hang Kwok, Stephen Wai Liu, Xian-Liang Wang, Tao Bressington, Daniel Shen, Yushan Zhang, Qing Huang, Hou-Qiang Tan, Jing-Yu Asia Pac J Oncol Nurs Original Article OBJECTIVE: To validate the Chinese version of the Quality of Life (QoL) Patient/Cancer Survivor Version (QOLCSV-C) for measuring QoL in Chinese cancer survivors. METHODS: The study followed a seven-step research practice guideline for cross-cultural research instrument validation study including translation, adaptation, and psychometric assessment. A forward- and backward-translation procedure was approached, followed by cultural adaptation and acceptability assessment. For its psychometric properties, its concurrent validity with the Functional Assessment of Cancer Therapy-General (FACT-G) was examined with correlation analysis. The internal consistency (Cronbach's alpha) and item-total and item–subtotal correlations of the QOLCSV-C were obtained. Factor analyses were conducted. Floor and ceiling effects and the discriminant performance of the selected variables on QOLCSV-C score were also examined. RESULTS: The QOLCSV-C was translated from the 41-item QOLCSV with four domains: psychological, physical, spiritual and social well-being. The content validity was excellent (CVI ​= ​1.00). Time spent to complete the QOLCSV-C was about 10 ​min. The QOLCSV-C was found easy to use, appropriate in length, and reflective of their QoL. The strong correlation between QOLCSV-C and FACT-G indicates a satisfactory concurrent validity (Spearman's rho ​= ​0.765, P ​< ​0.001, n ​= ​205). The overall internal consistency of the QOLCSV-C (Cronbach's alpha ​= ​0.888) and the split-half reliability (Spearman-Brown r ​= ​0.918) were excellent. Most of the items show moderate to strong item-total correlation. The exploratory factor analysis revealed a four-factor solution, and confirmatory factor analysis has a satisfactory model fit with indicative items. None of the total scores of QOLCSV-C reveal the floor or ceiling effect. For discriminant performance, variables demonstrating significant between-group differences include sleep quality, pain, fatigue, nausea, physical health, and financial burden. CONCLUSIONS: The QOLCSV-C is a reliable and valid instrument for measuring the QoL in Chinese cancer survivors. Future studies can explore the factor structure, gender universal or specific items, and significant predictors of QoL of cancer survivors in different cultures. Elsevier 2023-06-05 /pmc/articles/PMC10372171/ /pubmed/37519402 http://dx.doi.org/10.1016/j.apjon.2023.100255 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Wang, Hai-Ying
Hang Kwok, Stephen Wai
Liu, Xian-Liang
Wang, Tao
Bressington, Daniel
Shen, Yushan
Zhang, Qing
Huang, Hou-Qiang
Tan, Jing-Yu
Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title_full Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title_fullStr Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title_full_unstemmed Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title_short Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
title_sort quality of life patient/cancer survivor version in chinese cancer survivors: a validation study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372171/
https://www.ncbi.nlm.nih.gov/pubmed/37519402
http://dx.doi.org/10.1016/j.apjon.2023.100255
work_keys_str_mv AT wanghaiying qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT hangkwokstephenwai qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT liuxianliang qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT wangtao qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT bressingtondaniel qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT shenyushan qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT zhangqing qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT huanghouqiang qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy
AT tanjingyu qualityoflifepatientcancersurvivorversioninchinesecancersurvivorsavalidationstudy